289 related articles for article (PubMed ID: 19103883)
21. Gastrointestinal complications of HIV infection: changing priorities in the HAART era.
Wilcox CM; Saag MS
Gut; 2008 Jun; 57(6):861-70. PubMed ID: 18203808
[TBL] [Abstract][Full Text] [Related]
22. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.
Burgoyne RW; Tan DH
J Antimicrob Chemother; 2008 Mar; 61(3):469-73. PubMed ID: 18174196
[TBL] [Abstract][Full Text] [Related]
23. AIDS-related lymphomas--potentially curable in the HAART era.
Valencia ME
AIDS Rev; 2006; 8(2):108-10. PubMed ID: 16848278
[No Abstract] [Full Text] [Related]
24. HIV infection and the cardiovascular system.
Barbaro G; Klatt EC
AIDS Rev; 2002; 4(2):93-103. PubMed ID: 12152522
[TBL] [Abstract][Full Text] [Related]
25. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.
Zoufaly A; Stellbrink HJ; Heiden MA; Kollan C; Hoffmann C; van Lunzen J; Hamouda O;
J Infect Dis; 2009 Jul; 200(1):79-87. PubMed ID: 19476437
[TBL] [Abstract][Full Text] [Related]
26. [Cutaneous drug reactions in HIV-infected patients in the HAART era].
Blanes M; Belinchón I; Portilla J
Actas Dermosifiliogr; 2009 May; 100(4):253-65. PubMed ID: 19463228
[TBL] [Abstract][Full Text] [Related]
27. First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).
Carosi G; Quiros-Roldan E; Torti C; Antinori A; Bevilacqua M; Bonadonna RC; Bonfanti P; Castagna A; Cauda R; d'Arminio-Monforte A; Di Gregorio P; Di Perri G; Esposito R; Fatuzzo F; Gervasoni C; Giannattasio C; Guaraldi G; Lazzarin A; Lo Caputo S; Maggi P; Mazzotta F; Moroni M; Prestileo T; Ranieri R; Rizzardini G; Russo R; Galli M;
Infection; 2007 Jun; 35(3):134-42. PubMed ID: 17565453
[TBL] [Abstract][Full Text] [Related]
28. Changes in mortality following HIV and AIDS and estimation of the number of people living with diagnosed HIV/AIDS in Australia, 1981-2003.
Nakhaee F; Black D; Wand H; McDonald A; Law M
Sex Health; 2009 Jun; 6(2):129-34. PubMed ID: 19457292
[TBL] [Abstract][Full Text] [Related]
29. [Prophylaxis against adverse effects of chemotherapy for HIV positive patients].
Bentata M
Bull Cancer; 2003 May; 90(5):427-34. PubMed ID: 12850766
[TBL] [Abstract][Full Text] [Related]
30. HIV and hyperlipidemia: current recommendations and treatment.
Capili B; Anastasi JK
Medsurg Nurs; 2006 Feb; 15(1):14-9, 35; quiz 20. PubMed ID: 16583530
[TBL] [Abstract][Full Text] [Related]
31. Impact of HAART therapy on co-infection of tuberculosis and HIV cases for 9 years in Taiwan.
Tseng SH; Jiang DD; Hoi HS; Yang SL; Hwang KP
Am J Trop Med Hyg; 2009 Apr; 80(4):675-7. PubMed ID: 19346398
[TBL] [Abstract][Full Text] [Related]
32. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
33. The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphoma.
Clayton G; Omasta-Martin A; Bower M
J HIV Ther; 2006 Sep; 11(3):51-3. PubMed ID: 17580498
[No Abstract] [Full Text] [Related]
34. Sexual dysfunction in the highly active antiretroviral therapy era.
Collazos J
AIDS Rev; 2007; 9(4):237-45. PubMed ID: 18219367
[TBL] [Abstract][Full Text] [Related]
35. High coverage with HAART is required to substantially reduce the number of deaths from tuberculosis: system dynamics simulation.
Atun RA; Lebcir RM; Drobniewski F; McKee M; Coker RJ
Int J STD AIDS; 2007 Apr; 18(4):267-73. PubMed ID: 17509178
[TBL] [Abstract][Full Text] [Related]
36. Pediatric human immunodeficiency virus infection and cancer in the highly active antiretroviral treatment (HAART) era.
Chiappini E; Berti E; Gianesin K; Petrara MR; Galli L; Giaquinto C; de Martino M; De Rossi A
Cancer Lett; 2014 May; 347(1):38-45. PubMed ID: 24513180
[TBL] [Abstract][Full Text] [Related]
37. Socio-economic impact of antiretroviral treatment in HIV patients. An economic review of cost savings after introduction of HAART.
Gonzalo T; García Goñi M; Muñoz-Fernández MA
AIDS Rev; 2009; 11(2):79-90. PubMed ID: 19529748
[TBL] [Abstract][Full Text] [Related]
38. [New spectrum of HIV-associated cognitive disorders in the HAART era].
Du Pasquier R; Cavassini M; Simioni S; Annoni JM; Giacobini E; Hirschel B
Rev Med Suisse; 2009 Apr; 5(201):955-6, 958-61. PubMed ID: 19476058
[TBL] [Abstract][Full Text] [Related]
39. The impact of human genetic variation on HIV disease in the era of HAART.
Brumme ZL; Harrigan PR
AIDS Rev; 2006; 8(2):78-87. PubMed ID: 16848275
[TBL] [Abstract][Full Text] [Related]
40. Effects of highly active antiretroviral therapy among HIV-infected patients. Results from randomised and observational studies.
Kirk O
Dan Med Bull; 2004 Feb; 51(1):63-81. PubMed ID: 16009072
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
